We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Revolutionary Bead-Based Technology Enables Reliable Biomarker Detection in Challenging Samples

By LabMedica International staff writers
Posted on 30 Jun 2023

Millions of assays are performed every day in clinical laboratories worldwide, with the quest for specific biomarkers to identify early-stage diseases becoming increasingly important. More...

However, the variety of patient sample types, including blood, saliva, and urine, can often lead to false positives or negatives. Now, a groundbreaking technology allows for reliable biomarker detection in these complex samples, revolutionizing clinical diagnostic accuracy and research workflows.

Veravas (Austin, TX, USA) has introduced the VeraBIND (Biomarker Isolation and N-richment for Detection) technology, a unique and comprehensive solution that enhances biomarker detection accuracy and significantly reduces the potential for false positive or negative results across various sample types. VeraBINDing the sample during collection or preparation transforms complex samples into a matrix-free sample. This boosts the performance of existing tests and could facilitate a significant breakthrough in biomarker detection for healthcare professionals. With this revolutionary technology, clinical laboratories can optimize their diagnostic processes, contributing to the early detection of diseases and enabling timely, targeted interventions.

VeraBIND also speeds up assay development, ensuring consistency and improved accuracy in research, clinical trials, and diagnostic tests. This technology, designed for clinical diagnostics and research, enhances workflows and facilitates more sensitive detection of low abundance or previously hidden biomarkers. Once validated, it is compatible with commercially available assays and can be run using any detection method, such as ELISA, chemiluminescence, and mass spectrometry. Veravas, through VeraBIND, is revolutionizing assay development and biomarker detection, setting a new standard in clinical diagnostics and research. With improved accuracy and streamlined workflows, clinicians and researchers can expect better outcomes and improved quality of life for patients globally.

"VeraBIND is a game-changer for the clinical diagnostics industry, as it addresses the most difficult challenges in assay development," said John Forrest, CEO of Veravas. "By standardizing and simplifying the sample matrix, we are revolutionizing early biomarker detection for Alzheimer's and other diseases, leading to better patient outcomes."

"By creating a new matrix-free sample, VeraBIND enables biomarkers to be examined easily, offering clinicians faster, more accurate testing and diagnosis," said Josh Soldo, Chief Scientific Officer at Veravas. "Eliminating sample interferences and enriching biomarkers of interest results in superior detection. This advancement ensures assays leveraging VeraBIND can be standardized for more efficient analysis."

Related Links:
Veravas 


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Hemoglobin/Haptoglobin Assay
IDK Hemoglobin/Haptoglobin Complex ELISA
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The POC device rapidly predicts neonatal respiratory disease at birth in the NICU (Photo courtesy of SIME Diagnostics)

AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. This group is at an elevated risk for respiratory distress,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: This image shows a second-generation version of the device that can also measure cell morphology (Photo courtesy of MIT)

Rapid Cell Density Measurement Technique to Help Predict Immunotherapy Response

The density of a cell provides valuable insights into its condition. As cells go through processes such as proliferation, differentiation, or cell death, they may gain or lose water and other molecules,... Read more

Technology

view channel
Image: Scanning electron microscopy images showing 3D micro-printed Limacon-shaped whispering-gallery-mode microcavities with different amounts of deformation (Photo courtesy of A. Ping Zhang/PolyU)

Tiny Microlaser Sensors with Supercharged Biosensing Ability to Enable Early Disease Diagnosis

Optical whispering-gallery-mode microlaser sensors function by trapping light within tiny microcavities. When target molecules bind to the cavity, they induce subtle changes in the laser’s frequency, allowing... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.